Impact of antithrombin III concentrates on portal vein thrombosis after splenectomy in patients with liver cirrhosis and hypersplenism

Annals of Surgery

Volumn 251, Issue 1, 2010, Pages 76-83

  Kawanaka, Hirofumi ^a,b   Akahoshi, Tomohiko ^a   Kinjo, Nao ^a   Konishi, Kozou ^a   Yoshida, Daisuke ^a   Anegawa, Go ^a   Yamaguchi, Shohei ^a   Uehara, Hideo ^a   Hashimoto, Naotaka ^a   Tsutsumi, Norifumi ^a   Tomikawa, Morimasa ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Fukuoka City Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHROBIN P; ANTITHROMBIN III CONCENTRATE; HEPARIN; UNCLASSIFIED DRUG; WARFARIN; ANTICOAGULANT AGENT; ANTITHROMBIN III; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HYPERSPLENISM; LAPAROSCOPIC SURGERY; LIVER CIRRHOSIS; MALE; PORTAL VEIN THROMBOSIS; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RISK FACTOR; SPLEEN WEIGHT; SPLENECTOMY; THROMBOCYTE COUNT; THROMBOSIS PREVENTION; BLOOD; COMPUTER ASSISTED TOMOGRAPHY; DOPPLER FLOWMETRY; INTRAVENOUS DRUG ADMINISTRATION; LAPAROSCOPY; MIDDLE AGED; PORTAL VEIN; POSTOPERATIVE CARE; PREOPERATIVE CARE; VEIN THROMBOSIS;

ADULT; AGED; ANTICOAGULANTS; ANTITHROMBIN III; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; HYPERSPLENISM; INFUSIONS, INTRAVENOUS; LAPAROSCOPY; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PORTAL VEIN; POSTOPERATIVE CARE; PREOPERATIVE CARE; RISK FACTORS; SPLENECTOMY; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, DOPPLER; VENOUS THROMBOSIS;

EID: 74049147437     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181bdf8ad     Document Type: Article

References (50)

1. Okuda K, Ohnishi K, Kimura K, et al. Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients. Gastroenterology. 1985;89:279-286.
2. Eguchi A, Hashizume M, Seigo K, et al. High rate of portal thrombosis after splenectomy in patients with esophageal varices and idiopathic portal hypertension. Arch Surg. 1991;126:254-257.
3. Nonami T, Yokoyama I, Iwatsuki S, et al. The incidence of portal vein thrombosis at liver transplantation. Hepatology. 1992;16:1195-1198.
4. Amitrano L, Guardascione MA, Brancacio V, et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepa-tol. 2004;40:736-741.
5. Francoz C, Belghiti J, Vilgrain V, et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagula-tion. Gut. 2005;54:691-697.
6. Amitrano L, Brancaccio V, Guardascione MA, et al. Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis. Hepatology. 2000;31:345-348.
7. Soper NJ, Rikkers LF. Effects of operations for variceal hemorrhage on hypersplenism. Am J Surg. 1982;144:700-703.
8. Tomikawa M, Hashizume M, Saku M, et al. Effectiveness of gastric devas-cularization and splenectomy for patients with gastric varices. J Am Coll Surg. 2000;191:498-503.
9. Sugawara Y, Yamamoto J, Shimada K, et al. Splenectomy in patients with hepatocellular carcinoma and hypersplenism. J Am Coll Surg. 2000;190:446-450.
10. Wu CC, Cheng SB, Ho WM, et al. Appraisal of concomitant splenectomy in liver resection for hepatocellular carcinoma in cirrhotic patients with hyper-splenic thrombocytopenia. Surgery. 2004;136:660-668.
11. Kercher KW, Carbonell AM, Heniford BT, et al. Laparoscopic splenectomy reverses thrombocytopenia in patients with hepatitis C cirrhosis and portal hypertension. J Gastrointest Surg. 2004;8:120-126.
12. Kawanaka H, Konishi K, Yoshida D, et al. Effects of laparoscopic splenec-tomy on the patients with hepatitis C cirrhosis and portal hypertension. Gastroenterology. 2007;132:A798.
13. Shimada M, Ijichi H, Yonemura Y, et al. The impact of splenectomy or splenic arterial ligation on the outcome of a living donor adult liver transplantation using a left lobe graft. Hepatogastroenterology. 2004;51:625-629.
14. Yagi S, Iida T, Hori T, et al. Optimal portal venous circulation for liver graft function after living-donor liver transplantation. Transplantation. 2006;81: 373-378.
15. Yoshizumi T, Taketomi A, Soejima Y, et al. The beneficial role of simultaneous splenectomy in living donor liver transplantation in patients with small-for-size graft. Transpl Int. 2008;21:833-842.
16. Hashizume M, Tomikawa M, Akahoshi T, et al. Laparoscopic splenectomy for portal hypertension. Hepatogastroenterology. 2002;49:847-852.
17. Winslow ER, Brunt LM, Drebin JA, et al. Portal vein thrombosis after splenectomy. Am J Surg. 2002;184:631-636.
18. Ikeda M, Sekimoto M, Takiguchi S, et al. High incidences of thrombosis of the portal venous system after laparoscopic splenectomy. Ann Surg. 2005; 241:208-216.
19. Soyer T, Ciftci AO, Tanyel FC, et al. Portal vein thrombosis after splenec-tomy in pediatric hematologic disease: risk factors, clinical features, and outcome. J Pediatr Surg. 2006;41:1899-1902. (Pubitemid 44709084)
20. Hanazaki K, Kajikawa S, Adachi W, et al. Portal vein thrombosis may be a fatal complication after synchronous splenectomy in patients with hepatocel-lular carcinoma and hypersplenism. J Am Coll Surg. 2000;191:341-342.
21. Manzanet G, Sanjuán F, Orbis P, et al. Liver transplantation in patients with portal vein thrombosis. Liver Transpl. 2001;7:125-131.
22. Condat B, Pessione F, Denninger MH, et al. Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy. Hepatology. 2000;32:466-470.
23. Condat B, Pessione F, Hillaire S, et al. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenter-ology. 2001;120:490-497.
24. Gando S, Sawamura A, Hayakawa M, et al. First day dynamic changes in antithrombin III activity after supplementation have a predictive value in critically ill patients. Am J Hematol. 2006;81:907-914.
25. Kaneko J, Sugawara Y, Tamura S, et al. Coagulation and fibrinolytic profiles and appropriate use of heparin after living-donor liver transplantation. Clin Transpl. 2005;19:804-809.
26. Petit P, Bret PM, Atri M, et al. Splenic vein thrombosis after splenectomy: frequency and role of imaging. Radiology. 1994;190:65-68.
27. Bach AM, Hann LE, Brown KT, et al. Portal vein evaluation with US: comparison to angiography combined with CT arterial portography. Radiology. 1996;201:149-154.
28. Dickson BC. Venous thrombosis: on the history of Virchow's triad. Univ Toronto Med J. 2004;81:166-171.
29. Denninger MH, Chaït Y, Casadevall N, et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepa-tology. 2000;31:587-591.
30. Primignani M, Martinelli I, Bucciarelli P, et al. Risk factors for thrombophilia in extrahepatic portal vein obstruction. Hepatology. 2005;41:603-608.
31. Webster GJ, Burroughs AK, Riordan SM. Review article: portal vein thrombosis-new insights into aetiology and management. Aliment Pharmacol Ther. 2005;21:1-9.
32. Zwiebel WJ, Mountford RA, Halliwell MJ, et al. Splanchnic blood flow in patients with cirrhosis and portal hypertension: investigation with duplex Doppler US. Radiology. 1995;194:807-812.
33. Shah SH, Hayes PC, Allan PL, et al. Measurement of spleen size and its relation to hypersplenism and portal hemodynamics in portal hypertension due to hepatic cirrhosis. Am J Gastroenterol. 1996;91:2580-2583.
34. Bolognesi M, Merkel C, Sacerdoti D, et al. Role of spleen enlargement in cirrhosis with portal hypertension. Dig Liver Dis. 2002;34:144-150.
35. Nishida O, Moriyasu F, Nakamura T, et al. Interrelationship between splenic and superior mesenteric venous circulation manifested by transient splenic arterial occlusion using a balloon catheter. Hepatology. 1987;7:442-446.
36. Knot E, Ten Cate JW, Drijfhout HR, et al. Antithrombin III metabolism in patients with liver disease. J Clin Pathol. 1984;37:523-530.
37. Lechner K, Niessner H, Thaler E. Coagulation abnormalities in liver disease. Semin Thromb Hemost. 1977;4:40-56.
38. Tytgat GN, Collen D, Verstraete M. Metabolism of fibrinogen in cirrhosis of the liver. J Clin Invest. 1971;50:1690-1701.
39. Schipper HG, ten Cate JW. Antithrombin III transfusion in patients with hepatic cirrhosis. Br J Haematol. 1982;52:25-33.
40. Langley PG, Hughes RD, Forbes A, et al. Controlled trial of antithrombin III supplementation in fulminant hepatic failure. J Hepatol. 1993;17:326-331.
41. Büller HR, ten Cate JW. Antithrombin III infusion in patients undergoing peritoneovenous shunt operation: failure in the prevention of disseminated intravascular coagulation. Thromb Haemost. 1983;49:128-131.
42. Shimada M, Matsumata T, Kamakura T, et al. Modulation of coagulation and fibrinolysis in hepatic resection: a randomized prospective control study using antithrombin III concentrates. Thromb Res. 1994;74:105-114.
43. Scherer R, Kabatnik M, Erhard J, et al. The influence of antithrombin III (AT III) substitution to supranormal activities on systemic procoagulant turnover in patients with end-stage chronic liver disease. Intensive Care Med. 1997; 23:1150-1158.
44. Lindberg F, Rasmussen I, Siegbahn A, et al. Coagulation activation after laparoscopic cholecystectomy in spite of thromboembolism prophylaxis. Surg Endosc. 2000;14:858-861.
45. Jakimowica J, Stultiens G, Smulders F. Laparoscopic insufflation of the abdominal reduces portal venous flow. Surg Endosc. 1998;12:129-132.
46. Tsugawa K, Hashizume M, Migou S, et al. The effect of carbon dioxide pneumoperitoneum on the portal hemodynamics in a portal-hypertensive rat model. Surg Laparosc Endosc Percutan Tech. 1999;9:338-347.
47. Svensson M, Wirén M, Kimby E, et al. Portal vein thrombosis is a common complication following splenectomy in patients with malignant haematologi-cal diseases. Eur J Haematol. 2006;77:203-209.
48. Pietrabissa A, Moretto C, Antonelli G, et al. Thrombosis in the portal venous system after elective laparoscopic splenectomy. Surg Endosc. 2004;18:1140-1143.
49. Chaffanjon PCJ, Brichon PY, Ranchoup Y, et al. Portal vein thrombosis following splenectomy for hematologic disease: prospective study with Doppler color flow imaging. World J Surg. 1998;22:1082-1086.
50. Van't Riet M, Burger JWA, van Muiswinkel JM, et al. Diagnosis and treatment of portal vein thrombosis following splenectomy. Br J Surg. 2000;87:1229-1233.